Oncogenic TRK fusions are amenable to inhibition in hematologic malignancies
Author:
Funder
NHLBI
NIH/NCI
U.S. Department of Defense
Publisher
American Society for Clinical Investigation
Subject
General Medicine
Link
https://www.jci.org/articles/view/120787/files/pdf
Reference23 articles.
1. Oncogenes in solid human tumours
2. A human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequences
3. Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma
4. Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity;Skálová;Am J Surg Pathol,2010
5. Infantile Fibrosarcoma With NTRK3–ETV6 Fusion Successfully Treated With the Tropomyosin‐Related Kinase Inhibitor LOXO‐101
Cited by 45 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Post-HSCT Maintenance Treatment Using Entrectinib for an AML Patient Accompanied with ETV6::NTRK3: A Case Report;OncoTargets and Therapy;2023-12
2. Strategic Approach to Heterogeneity Analysis of Cutaneous Adnexal Carcinomas Using Computational Pathology and Genomics;JID Innovations;2023-11
3. ETS transcription factors: Multifaceted players from cancer progression to tumor immunity;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2023-05
4. N-of-1 Trials in Cancer Drug Development;Cancer Discovery;2023-04-18
5. Targeted therapy using larotrectinib and venetoclax for the relapsed/refractory T‐cell acute lymphoblastic leukemia harboring a cryptic ETV6‐NTRK3 fusion;Molecular Carcinogenesis;2023-04-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3